Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 1/20 | 0.47 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.47 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.45 |
| ▸ | FYN | P06241 | 4/20 | 0.43 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.43 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2880093 | 0.95 | RAD52 (0.48) | CYP17A1CYP11B1CYP11B2ALDH1A1MEN1 | |
| SCHEMBL2319146 | 0.88 | FYN (0.51) | ALDH1A1MEN1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL2882272 | 0.82 | FYN (0.48) | CYP17A1CYP11B1CYP11B2ALDH1A1MEN1 | |
| SCHEMBL2880067 | 0.81 | SMN1; SMN2 (0.44) | CYP17A1CYP11B1CYP11B2ALDH1A1MEN1 | |
| SCHEMBL2212033 | 0.81 | FYN (0.44) | ALDH1A1MEN1KMT2ASMN1; SMN2FYN | |
| SCHEMBL2212035 | 0.81 | SMN1; SMN2 (0.39) | ALDH1A1MEN1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL2880155 | 0.79 | PLK1 (0.43) | CYP17A1CYP11B1CYP11B2ALDH1A1MEN1 | |
| SCHEMBL2211969 | 0.79 | FYN (0.44) | CYP17A1CYP11B1CYP11B2ALDH1A1MEN1 | |
| SCHEMBL2212656 | 0.78 | SMN1; SMN2 (0.35) | ALDH1A1MEN1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL2881428 | 0.78 | FYN (0.51) | CYP17A1CYP11B1CYP11B2ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7745446-B2 | Pyrazolo[1,5-c]pyrimidines | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-06-29 | — | — | US | disclosed |
| US-20070254046-A1 | Novel Pyrazolopyrimidines | ALTANA PHARMA AG (DE) | 2007-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070254046-A1 | Novel Pyrazolopyrimidines | MCL1, RARS2, CDK4 | CYP17A1 3208/4885CYP11B1 613/4885CYP11B2 512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.